About The CRC Digest

What this is

The CRC Digest reads the week's colorectal cancer research and explains it in plain language. Trial results, screening guidance, treatment updates, survivorship studies: each one summarized, put in context, and cited to its source.

It is written for a newly diagnosed patient trying to understand what is happening in research. Caregivers, researchers, and clinicians read it too. Every acronym is explained. Every finding comes with its limits stated.

What we will never do

We never give medical advice. We never describe early results as more than the evidence supports. We never use fear to hold your attention. Research summaries are information, not guidance: decisions about your care belong with you and your healthcare team.

How it is made

The CRC Digest is produced by Signal Bureau, an AI-native intelligence platform. Software reads the research stream continuously; every issue is curated with AI assistance and reviewed by the editorial team. Each claim carries its source, so you can read the original yourself. When we get something wrong, we say so and correct the record.

Read it your way

Issues arrive by email, free. The archive on this site is open: browse by topic, from KRAS mutations to screening to living with CRC, using the links at the bottom of any issue.

Subscribe free · Read the full disclaimer · Questions: hello@crcdigest.com

Subscribe to The CRC Digest

Sign up now to get access to the library of members-only issues.
jamie@example.com
Subscribe